Plain-English translation of NCT07041281 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether spironolactone, a blood pressure medication, can help protect the heart health of women who develop high blood pressure or preeclampsia during pregnancy. Women in the trial will take either the medication or a placebo (inactive pill) daily for 12 weeks after delivery. The goal is to see if treating blood pressure early after pregnancy can reduce the risk of developing chronic high blood pressure and heart problems later in life.
Women who have high blood pressure or preeclampsia during pregnancy face a higher risk of heart disease years later. Researchers believe that controlling blood pressure in the weeks right after delivery—when the body is especially sensitive to a certain hormone—could have lasting benefits for long-term heart health.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to take either spironolactone or placebo pills once daily for 12 weeks after your delivery. You'll need to visit the clinic for check-ups and blood tests to monitor your blood pressure and blood chemistry. The study takes place at three major hospitals, and researchers will follow how your blood pressure and heart health change over the three-month treatment period and beyond.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
United States